LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cancer, breast, article, google, scholar, pubmed, cas, chemotherapy, response, foxp, patients, neoadjuvant, prognostic, clin, res, regulatory, oncol, tregs, research, intratumoral, lymphocytes, complete, cells, tumor, izmir, clinical, pathologic, survival, predictive, pcr, rates, outcome, oncology, privacy, cookies, content, factors, locally, advanced, study, treg, pathological, infiltration, access, expression, kim, immune, turkey, department, publish,

Topics {✒️}

granulocyte/macrophage-colony stimulating factor-secreting month download article/chapter neoadjuvant anthracycline/taxane-based chemotherapy tumour-infiltrating foxp3+ lymphocytes de la torre-cabrera tumor-infiltrating lymphocytes isolated triple-negative breast cancer balancing immune response-crosstalk higher pre-chemotherapy tregs tumor t-lymphocyte infiltration predict clinical outcome tumour-infiltrating lymphocytes potential therapeutic target full article pdf doxorubicin-based neoadjuvant chemotherapy privacy choices/manage cookies immunosuppressive regulatory tcells regulatory tcell infiltration van de rjin tumor infiltrating lymphocytes good clinical outcome intratumoral foxp3+ regulatory pathologic complete response foxp3+ tumor-infiltrating meta-analysis related subjects cd8+ lymphocyte infiltration transcription factor foxp3 intratumoral foxp3+ lymphocytes pathological complete response high-risk patients independent predictive factor human malignancies based locallyadvanced breast cancer breast cancer progression inflammatory breast cancer breast cancer subtype operable breast cancer choose adjuvant therapies dokuz eylul university intratumoral foxp3+ tregs van nes jg breast cancer subtypes lower intratumoral infiltration situ immune response antitumor immune response anti-tumor effects early breast cancer european economic area mihm mc jr

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs
         description:This study aimed to investigate the prognostic and predictive effect of FOXP3+ Tregs together with clinicopathologic factors in locally advanced breast cancer (LABC) patients. The medical records of 101 LABC patients who received neoadjuvant chemotherapy (NAC) between 2005 and 2012 were evaluated retrospectively. The density of intratumoral FOXP3+ lymphocytes in paraffin-embedded tissues was assessed by immunohistochemical analyses in appropriate cases. The relationship with clinicopathologic features, prognosis and chemotherapy response was investigated. HR(–) and HER2(+) tumors tended to have higher pre-chemotherapy Tregs than HR(+) tumors, and significantly higher pathologic complete response (PCR) rates were observed in these patients. Treg decline after NAC was associated with better pathological response rates. Lower intratumoral infiltration of FOXP3+ Tregs after NAC (<3.4/HPF) was significantly associated with higher PCR rates for breast, and close to the significance limit for total (or both for breast and axillary) PCR rates (PCR for breast: 25 vs. 2.9 % for low vs. high Treg, p = 0.001; PCR for breast + axillary tissue: 13.9 vs. 0 %, p = 0.05). Despite better PCR rates, patients with high intratumoral Treg infiltrates (≥11.5/HPF) before chemotherapy had significantly shorter overall survival than patients with low Treg infiltrates (<11.5/HPF). Cox multivariate regression analyses demonstrated that the density of Treg infiltration before chemotherapy was the strongest predictor for survival. This study established the predictive and prognostic effect of intratumoral FOXP3+ Tregs in LABC patients. To predict clinical outcome, evaluation of FOXP3+ Tregs in tumoral tissues before and after NAC should be considered for these high-risk patients.
         datePublished:2013-07-09T00:00:00Z
         dateModified:2013-07-09T00:00:00Z
         pageStart:1047
         pageEnd:1062
         sameAs:https://doi.org/10.1007/s10585-013-9602-9
         keywords:
            Breast cancer
            FOXP3+ T lymphocytes
            Neoadjuvant chemotherapy
            Pathologic complete response
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig4_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:30
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lutfiye Demir
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Seyran Yigit
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hulya Ellidokuz
               affiliation:
                     name:Dokuz Eylul University
                     address:
                        name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cigdem Erten
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isil Somali
               affiliation:
                     name:Dokuz Eylul University
                     address:
                        name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuksel Kucukzeybek
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmet Alacacioglu
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suna Cokmert
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alper Can
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Murat Akyol
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmet Dirican
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vedat Bayoglu
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aysegul Akder Sari
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mustafa Oktay Tarhan
               affiliation:
                     name:Izmir Katip Celebi University
                     address:
                        name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs
      description:This study aimed to investigate the prognostic and predictive effect of FOXP3+ Tregs together with clinicopathologic factors in locally advanced breast cancer (LABC) patients. The medical records of 101 LABC patients who received neoadjuvant chemotherapy (NAC) between 2005 and 2012 were evaluated retrospectively. The density of intratumoral FOXP3+ lymphocytes in paraffin-embedded tissues was assessed by immunohistochemical analyses in appropriate cases. The relationship with clinicopathologic features, prognosis and chemotherapy response was investigated. HR(–) and HER2(+) tumors tended to have higher pre-chemotherapy Tregs than HR(+) tumors, and significantly higher pathologic complete response (PCR) rates were observed in these patients. Treg decline after NAC was associated with better pathological response rates. Lower intratumoral infiltration of FOXP3+ Tregs after NAC (<3.4/HPF) was significantly associated with higher PCR rates for breast, and close to the significance limit for total (or both for breast and axillary) PCR rates (PCR for breast: 25 vs. 2.9 % for low vs. high Treg, p = 0.001; PCR for breast + axillary tissue: 13.9 vs. 0 %, p = 0.05). Despite better PCR rates, patients with high intratumoral Treg infiltrates (≥11.5/HPF) before chemotherapy had significantly shorter overall survival than patients with low Treg infiltrates (<11.5/HPF). Cox multivariate regression analyses demonstrated that the density of Treg infiltration before chemotherapy was the strongest predictor for survival. This study established the predictive and prognostic effect of intratumoral FOXP3+ Tregs in LABC patients. To predict clinical outcome, evaluation of FOXP3+ Tregs in tumoral tissues before and after NAC should be considered for these high-risk patients.
      datePublished:2013-07-09T00:00:00Z
      dateModified:2013-07-09T00:00:00Z
      pageStart:1047
      pageEnd:1062
      sameAs:https://doi.org/10.1007/s10585-013-9602-9
      keywords:
         Breast cancer
         FOXP3+ T lymphocytes
         Neoadjuvant chemotherapy
         Pathologic complete response
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-013-9602-9/MediaObjects/10585_2013_9602_Fig4_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:30
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lutfiye Demir
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Seyran Yigit
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hulya Ellidokuz
            affiliation:
                  name:Dokuz Eylul University
                  address:
                     name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cigdem Erten
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isil Somali
            affiliation:
                  name:Dokuz Eylul University
                  address:
                     name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuksel Kucukzeybek
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmet Alacacioglu
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suna Cokmert
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alper Can
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Murat Akyol
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmet Dirican
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vedat Bayoglu
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aysegul Akder Sari
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mustafa Oktay Tarhan
            affiliation:
                  name:Izmir Katip Celebi University
                  address:
                     name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:30
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Dokuz Eylul University
      address:
         name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Dokuz Eylul University
      address:
         name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
      name:Izmir Katip Celebi University
      address:
         name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lutfiye Demir
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Seyran Yigit
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Hulya Ellidokuz
      affiliation:
            name:Dokuz Eylul University
            address:
               name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Cigdem Erten
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Isil Somali
      affiliation:
            name:Dokuz Eylul University
            address:
               name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Yuksel Kucukzeybek
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Ahmet Alacacioglu
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Suna Cokmert
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Alper Can
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Murat Akyol
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Ahmet Dirican
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Vedat Bayoglu
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Aysegul Akder Sari
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
      name:Mustafa Oktay Tarhan
      affiliation:
            name:Izmir Katip Celebi University
            address:
               name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
      name:Department of Medical Oncology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(169)

• How profitable is https://www.springernature.com/gp/authors?
• Earnings of https://link.springernature.com/home/
• What's the financial outcome of https://order.springer.com/public/cart?
• What is the monthly revenue of https://submission.nature.com/new-submission/10585/3?
• Income figures for https://www.springernature.com/gp/librarians/licensing/agc/journals
• How much does https://doi.org/10.3322%2Fcaac.20073 gross monthly?
• How much income is http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202010&journal=Cancer%20J%20Clin&doi=10.3322%2Fcaac.20073&volume=60&pages=277-300&publication_year=2010&author=Jemal%2CA&author=Siegel%2CR&author=Xu%2CJ&author=Ward%2CE earning monthly?
• How much cash flow does https://doi.org/10.1016%2Fj.ejso.2008.03.015 have monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18502088 produce monthly?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20chemotherapy%20for%20locally%20advanced%20breast%20cancer%3A%20a%20review%20of%20the%20literature%20and%20future%20directions&journal=Eur%20J%20Surg%20Oncol&doi=10.1016%2Fj.ejso.2008.03.015&volume=35&pages=113-122&publication_year=2009&author=Mathew%2CJ&author=Asgeirsson%2CKS&author=Cheung%2CKL&author=Chan%2CS&author=Dahda%2CA&author=Robertson%2CJF?
• How much does https://doi.org/10.1002%2Fpath.889 make?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11568890?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Towards%20a%20novel%20classification%20of%20human%20malignancies%20based%20on%20gene%20expression%20patterns&journal=J%20Pathol&doi=10.1002%2Fpath.889&volume=195&pages=41-52&publication_year=2001&author=Alizadeh%2CAA&author=Ross%2CDT&author=Perou%2CCM&author=Rjin%2CM?
• How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20course%20of%20breast%20cancer%20patients%20with%20complete%20pathologic%20primary%20tumor%20an%20axillary%20lymph%20node%20response%20to%20doxorubicin-based%20neoadjuvant%20chemotherapy&journal=J%20Clin%20Oncol&volume=17&pages=460-469&publication_year=1999&author=Kuere%2CHM&author=Newman%2CLA&author=Smith%2CTL&author=Ames%2CFC&author=Hunt%2CKK&author=Dhingra%2CK&author=Theriault%2CRL&author=Singh%2CG&author=Binkley%2CSM&author=Sneige%2CN&author=Buchholz%2CTA&author=Ross%2CMI&author=McNeese%2CMD&author=Buzdar%2CAU&author=Hortobagyi%2CGN&author=Singletary%2CSE generate monthly?
• What's the financial outcome of https://doi.org/10.1016%2FS0960-9776%2811%2970312-5?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Lessons%20from%20the%20neoadjuvant%20setting%20on%20how%20best%20to%20choose%20adjuvant%20therapies&journal=Breast&doi=10.1016%2FS0960-9776%2811%2970312-5&volume=20&pages=S142-S145&publication_year=2011&author=Minckwitz%2CG&author=Loibl%2CS&author=Maisch%2CA&author=Untch%2CM produce monthly?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18940745
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Tumor%20molecular%20subtyping%20according%20to%20hormone%20receptors%20and%20HER2%20status%20defines%20different%20pathological%20complete%20response%20to%20neoadjuvant%20chemotherapy%20in%20patients%20with%20locallyadvanced%20breast%20cancer&journal=Clin%20Transl%20Oncol&doi=10.1007%2Fs12094-008-0265-y&volume=10&publication_year=2008&author=Sanchez-Munoz%2CA&author=Garcia-Tapiador%2CAM&author=Martinez-Ortega%2CE&author=Due%C3%B1as-Garc%C3%ADa%2CR&author=Ja%C3%A9n-Morago%2CA&author=Ortega-Granados%2CAL&author=Fern%C3%A1ndez-Navarro%2CM&author=Torre-Cabrera%2CC&author=Due%C3%B1as%2CB&author=Rueda%2CAI&author=Morales%2CF&author=Ram%C3%ADrez-Torosa%2CC&author=Mart%C3%ADn-Salvago%2CMD&author=S%C3%A1nchez-Rovira%2CP?
• Income figures for https://doi.org/10.1200%2FJCO.2006.05.6861
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16896004's financial summary
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Pharmacogenomic%20predictor%20of%20sensitivity%20to%20preoperative%20chemotherapy%20with%20paclitaxel%20and%20fluorouracil%2C%20doxorubicin%2C%20and%20cyclophosphamide%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.05.6861&volume=24&pages=4236-4244&publication_year=2006&author=Hess%2CKR&author=Anderson%2CK&author=Symmans%2CWF&author=Valero%2CV&author=Ibrahim%2CN&author=Mejia%2CJA&author=Booser%2CD&author=Theriault%2CRL&author=Buzdar%2CAU&author=Dempsey%2CPJ&author=Rouzier%2CR&author=Sneige%2CN&author=Ross%2CJS&author=Vidaurre%2CT&author=G%C3%B3mez%2CHL&author=Hortobagyi%2CGN&author=Pusztai%2CL produce monthly?
• Monthly income for https://doi.org/10.1158%2F1078-0432.CCR-05-0507
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16243804 make?
• How much profit is http://scholar.google.com/scholar_lookup?&title=p53%20Codon%2072%20polymorphism%20predicts%20the%20pathologic%20response%20to%20neoadjuvant%20chemotherapy%20in%20patients%20with%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0507&volume=11&pages=7328-7333&publication_year=2005&author=Xu%2CY&author=Yao%2CL&author=Ouyang%2CT&author=Li%2CJ&author=Wang%2CT&author=Fan%2CZ&author=Lin%2CB&author=Lu%2CY&author=Xie%2CY making per month?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17976237?
• How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20clinicopathologic%20parameters%20in%20stage%20II%2FIII%20breast%20cancer%20treated%20with%20neoadjuvant%20docetaxel%20and%20doxorubicin%20chemotherapy%3A%20paradoxical%20features%20of%20the%20triple%20negative%20breast%20cancer&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-7-203&volume=7&publication_year=2007&author=Keam%2CB&author=Im%2CSA&author=Kim%2CHJ&author=Oh%2CDY&author=Kim%2CJH&author=Lee%2CSH&author=Chie%2CEK&author=Han%2CW&author=Kim%2CDW&author=Moon%2CWK&author=Kim%2CTY&author=Park%2CIA&author=Noh%2CDY&author=Heo%2CDS&author=Ha%2CSW&author=Bang%2CYJ bring in each month?
• What's the financial gain of https://doi.org/10.1038%2Fsj.bjc.6602419?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15700032?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=The%20relationship%20between%20tumor%20T-lymphocyte%20infiltration%2C%20the%20systemic%20inflammatory%20response%20and%20survival%20in%20patients%20undergoing%20curative%20resection%20for%20colorectal%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6602419&volume=92&pages=651-654&publication_year=2005&author=Canna%2CK&author=McArdle%2CPA&author=McMillan%2CDC&author=McNicol%2CAM&author=Smith%2CGW&author=McKee%2CRF&author=McArdle%2CCS
• How much revenue does https://doi.org/10.1002%2F1097-0142%2819890101%2963%3A1%3C102%3A%3AAID-CNCR2820630117%3E3.0.CO%3B2-T produce monthly?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2642728?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Functional%20and%20phenotypic%20analysis%20of%20tumor-infiltrating%20lymphocytes%20isolated%20from%20human%20primary%20and%20metastatic%20liver%20tumors%20and%20cultured%20in%20recombinant%20interleukin-2&journal=Cancer&doi=10.1002%2F1097-0142%2819890101%2963%3A1%3C102%3A%3AAID-CNCR2820630117%3E3.0.CO%3B2-T&volume=63&pages=102-111&publication_year=1989&author=Takagi%2CS&author=Chen%2CK&author=Schwarz%2CR&author=Iwatsuki%2CS&author=Herberman%2CRB&author=Whiteside%2CTL?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19338264 making per month?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Focus%20on%20TILs%3A%20prognostic%20significance%20of%20tumor%20infiltrating%20lymphocytes%20in%20human%20melanoma&journal=Cancer%20Immun&volume=9&publication_year=2009&author=Oble%2CDA&author=Loewe%2CR&author=Yu%2CP&author=Mihm%2CMC earns monthly
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17705880
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Inflammation%20and%20breast%20cancer%3A%20balancing%20immune%20response-crosstalk%20between%20adaptive%20and%20innate%20immune%20cells%20during%20breast%20cancer%20progression&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr1746&volume=9&publication_year=2007&author=DeNardo%2CDG&author=Coussens%2CLM?
• What is the monthly revenue of https://doi.org/10.1016%2Fj.ejca.2009.02.014?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19286369 bring in?
• http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20inflammation%20and%20medullary%20histological%20type%20in%20invasive%20carcinoma%20of%20the%20breast&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2009.02.014&volume=45&pages=1780-1787&publication_year=2009&author=Rakha%2CEA&author=Aleskandarany%2CM&author=Sayed%2CME&author=Blamey%2CRW&author=Elston%2CCW&author=Ellis%2CIO&author=Lee%2CAH's revenue stream
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18294387 each month?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=FOXP3%2B%20Tregs%20and%20B7-H1%2B%2FPD-1%2B%20T%20lymphocytes%20co-infiltrate%20the%20tumor%20tissues%20of%20high-risk%20breast%20cancer%20patients%3A%20implication%20for%20immunotherapy&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-8-57&volume=8&publication_year=2008&author=Ghebeh%2CH&author=Barhoush%2CE&author=Tulbah%2CA&author=Elkum%2CN&author=Al-Tweigeri%2CT&author=Dermime%2CS
• Monthly income for https://doi.org/10.1200%2FJCO.2010.30.5037
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21483002 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20CD8%2B%20lymphocytes%20predict%20clinical%20outcome%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2010.30.5037&volume=29&pages=1949-1955&publication_year=2011&author=Mahmoud%2CSM&author=Paish%2CEC&author=Powe%2CDG&author=Macmillan%2CRD&author=Grainge%2CMJ&author=Lee%2CAH&author=Ellis%2CIO&author=Green%2CAR generate monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22420471 produce monthly?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=CD8%2B%20lymphocyte%20infiltration%20is%20an%20independent%20favourable%20prognostic%20indicator%20in%20basal-like%20breast%20cancer&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr3148&volume=14&publication_year=2012&author=Liu%2CS&author=Lachapelle%2CJ&author=Leung%2CS&author=Gao%2CD&author=Foulkes%2CWD&author=Nielsen%2CTO?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20092246 generate?
• http://scholar.google.com/scholar_lookup?&title=Possible%20significance%20of%20differences%20in%20proportions%20of%20cytotoxic%20T%20cells%20and%20B-lineage%20cells%20in%20the%20tumour-infiltrating%20lymphocytes%20of%20typical%20and%20atypical%20medullary%20carcinomas%20of%20the%20breast&journal=Cancer%20Immun&volume=10&publication_year=2010&author=Lim%2CKH&author=Telisinghe%2CPU&author=Abdullah%2CMS&author=Ramasamy%2CR's total income per month
• How much does https://doi.org/10.1126%2Fscience.1079490 bring in each month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12522256's revenue stream
• Find out how much http://scholar.google.com/scholar_lookup?&title=Control%20of%20regulatory%20T%20cell%20development%20by%20the%20transcription%20factor%20FoxP3&journal=Science&doi=10.1126%2Fscience.1079490&volume=299&pages=1057-1061&publication_year=2003&author=Hori%2CS&author=Monura%2CT&author=Sakaguchi%2CS earns monthly
• How much profit is https://doi.org/10.1038%2Fmodpathol.2008.160 making per month?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18820666?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Immunosuppressive%20regulatory%20Tcells%20are%20associated%20with%20aggressive%20breast%20cancer%20phenotypes%3A%20a%20potential%20therapeutic%20target&journal=Mod%20Pathol&doi=10.1038%2Fmodpathol.2008.160&volume=21&pages=1527-1532&publication_year=2008&author=Bohling%2CSD&author=Allison%2CKH
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21717105?
• How much does http://scholar.google.com/scholar_lookup?&title=CD8%28%2B%29%20cytotoxic%20T%20cell%20and%20FOXP3%28%2B%29%20regulatory%20Tcell%20infiltration%20in%20relation%20to%20breast%20cancer%20survival%20and%20molecular%20subtypes&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1647-3&volume=130&pages=645-655&publication_year=2011&author=Liu%2CF&author=Lang%2CR&author=Zhao%2CJ&author=Zhang%2CX&author=Pringle%2CGA&author=Fan%2CY&author=Yin%2CD&author=Gu%2CF&author=Yao%2CZ&author=Fu%2CL earn?
• How much does https://doi.org/10.1200%2FJCO.2009.23.7370 pull in monthly?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19917869
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20lymphocytes%20as%20an%20independent%20predictor%20of%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.23.7370&volume=28&pages=105-113&publication_year=2010&author=Denkert%2CC&author=Loibl%2CS&author=Noske%2CA&author=Roller%2CM&author=M%C3%BCller%2CBM&author=Komor%2CM&author=Budczies%2CJ&author=Darb-Esfahani%2CS&author=Kronenwett%2CR&author=Hanusch%2CC&author=T%C3%B6rne%2CC&author=Weichert%2CW&author=Engels%2CK&author=Solbach%2CC&author=Schrader%2CI&author=Dietel%2CM&author=Minckwitz%2CG is on a monthly basis
• Discover the revenue of https://doi.org/10.1158%2F1078-0432.CCR-07-4491
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18413832
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Pathologic%20complete%20response%20to%20neoadjuvant%20chemotherapy%20of%20breast%20cancer%20is%20associated%20with%20the%20disappearence%20of%20tumor-infiltrating%20FOXP3%2B%20regulatory%20Tcells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4491&volume=14&pages=2413-2420&publication_year=2008&author=Ladoire%2CS&author=Arnould%2CL&author=Apetoh%2CL&author=Coudert%2CB&author=Martin%2CF&author=Chauffert%2CB&author=Fumoleau%2CP&author=Ghiringhelli%2CF?
• What's the profit of https://doi.org/10.1002%2Fpath.2866?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21437909 earning monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=In%20situ%20immune%20response%20after%20neoadjuvant%20chemotherapy%20for%20breast%20cancer%20predicts%20survival&journal=J%20Pathol&doi=10.1002%2Fpath.2866&volume=224&pages=389-400&publication_year=2011&author=Ladoire%2CS&author=Mignot%2CG&author=Dabakuyo%2CS&author=Arnould%2CL&author=Apetoh%2CL&author=R%C3%A9b%C3%A9%2CC&author=Coudert%2CB&author=Martin%2CF&author=Bizollon%2CMH&author=Vanoli%2CA&author=Coutant%2CC&author=Fumoleau%2CP&author=Bonnetain%2CF&author=Ghiringhelli%2CF bring in each month?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22842982 earns monthly
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Peritumoral%20FOXP3%2B%20regulatory%20Tcell%20is%20sensitive%20to%20chemotherapy%20while%20intratumoral%20FOXP3%2B%20regulatory%20T%20cell%20is%20prognostic%20predictor%20of%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-012-2132-3&volume=135&pages=459-467&publication_year=2012&author=Liu%2CF&author=Li%2CY&author=Ren%2CM&author=Zhang%2CX&author=Guo%2CX&author=Lang%2CR&author=Gu%2CF&author=Fu%2CL?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10888772
• See how much http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20in%20breast%20cancer.%20College%20of%20American%20pathologists%20consensus%20statement%201999&journal=Arch%20Pathol%20Lab%20Med&volume=124&pages=966-978&publication_year=2000&author=Fitzgibbons%2CPL&author=Page%2CDL&author=Weaver%2CD&author=Thor%2CAD&author=Allred%2CDC&author=Clark%2CGM&author=Ruby%2CSG&author=O%E2%80%99Malley%2CF&author=Simpson%2CJF&author=Connolly%2CJL&author=Hayes%2CDF&author=Edge%2CSB&author=Lichter%2CA&author=Schnitt%2CSJ makes per month
• Financial intake of https://doi.org/10.1016%2Fj.ejca.2008.10.026
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774 generate monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ&author=Schwartz%2CLH&author=Sargent%2CD&author=Ford%2CR&author=Dancey%2CJ&author=Arbuck%2CS&author=Gwyther%2CS&author=Mooney%2CM&author=Rubinstein%2CL&author=Shankar%2CL&author=Dodd%2CL&author=Kaplan%2CR&author=Lacombe%2CD&author=Verweij%2CJ
• How much money does https://doi.org/10.3109%2F0284186X.2012.731520 make?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23075422?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20FOXP3%20expression%20in%20triple-negative%20breast%20cancer&journal=Acta%20Oncol&doi=10.3109%2F0284186X.2012.731520&volume=52&pages=73-81&publication_year=2013&author=Lee%2CS&author=Cho%2CEY&author=Park%2CYH&author=Ahn%2CJS&author=Im%2CYH
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17629742 bring in each month?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20affecting%20locoregional%20recurrence%20in%20patients%20with%20stage%20IIIB%20noninflammatory%20breast%20cancer&journal=World%20J%20Surg&doi=10.1007%2Fs00268-007-9139-7&volume=31&pages=1724-1730&publication_year=2007&author=G%C3%BClben%2CK&author=Berbero%C4%9Flu%2CU&author=Cengiz%2CA&author=Altinyollar%2CH?
• How much revenue does https://doi.org/10.1001%2Farchsurg.141.6.567 produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16785357 bring in each month?
• How much profit is http://scholar.google.com/scholar_lookup?&title=A%20single-center%20experience%20with%20inflammatory%20breast%20cancer%2C%201985%E2%80%932003&journal=Arch%20Surg&doi=10.1001%2Farchsurg.141.6.567&volume=141&pages=567-573&publication_year=2006&author=Smoot%2CRL&author=Koch%2CCA&author=Degnim%2CAC&author=Sterioff%2CS&author=Donohue%2CJH&author=Grant%2CCS&author=Barnes%2CSA&author=Gullerud%2CRE&author=Hobday%2CTJ&author=Farley%2CDR making per month?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20443786 earns monthly
• How much does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20chemotherapy%20of%20breast%20cancer%3A%20tumor%20markers%20as%20predictors%20of%20pathologic%20response%2C%20recurrence%2C%20and%20survival&journal=Breast%20J&volume=16&pages=362-368&publication_year=2010&author=Precht%2CLM&author=Lowe%2CKA&author=Atwood%2CM&author=Beatty%2CJD pull in monthly?
• How much does https://doi.org/10.1245%2Fs10434-010-1008-1 earn?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20373039?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20relevance%20of%20breast%20cancer%20subtypes%20in%20the%20outcome%20of%20neoadjuvant%20chemotherapy&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-010-1008-1&volume=17&pages=2411-2418&publication_year=2010&author=Straver%2CME&author=Rutgers%2CEJ&author=Rodenhuis%2CS&author=Linn%2CSC&author=Loo%2CCE&author=Wesseling%2CJ&author=Russell%2CNS&author=Oldenburg%2CHS&author=Antonini%2CN&author=Vrancken%20Peeters%2CMT?
• https://doi.org/10.1093%2Fannonc%2Fmdm509's financial summary
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17986623?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20ER%2C%20PgR%2C%20HER1%2C%20HER2%2C%20and%20response%3A%20a%20study%20of%20preoperative%20chemotherapy&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm509&volume=19&pages=465-472&publication_year=2008&author=Colleoni%2CM&author=Viale%2CG&author=Zahrieh%2CD&author=Bottiglieri%2CL&author=Gelber%2CRD&author=Veronesi%2CP&author=Balduzzi%2CA&author=Torrisi%2CR&author=Luini%2CA&author=Intra%2CM&author=Dellapasqua%2CS&author=Cardillo%2CA&author=Ghisini%2CR&author=Peruzzotti%2CG&author=Goldhirsch%2CA
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19758440
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20biology-based%20breast%20cancer%20types%20with%20distinct%20predicitive%20and%20prognostic%20features%3A%20role%20of%20steroid%20hormone%20and%20HER2%20receptor%20expression%20in%20patients%20treated%20with%20neoadjuvant%20anthracycline%2Ftaxane-based%20chemotherapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2363&volume=11&publication_year=2009&author=Darb-Esfahani%2CS&author=Loibl%2CS&author=Muller%2CBM&author=Roller%2CM&author=Denkert%2CC&author=Komor%2CM&author=Schl%C3%BCns%2CK&author=Blohmer%2CJU&author=Budczies%2CJ&author=Gerber%2CB&author=Noske%2CA&author=Bois%2CA&author=Weichert%2CW&author=Jackisch%2CC&author=Dietel%2CM&author=Richter%2CK&author=Kaufmann%2CM&author=Minckwitz%2CG
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22198468 make?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20response%20and%20recurrence-free%20survival%20in%20neoadjuvant%20breast%20cancer%20depends%20on%20biomarker%20profiles%3A%20results%20from%20the%20I-SPY%201%20TRIAL%20%28CALBG%20150007%2F150012%3BACRIN%206657%29&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1895-2&volume=132&pages=1049-1062&publication_year=2012&author=Esserman%2CLJ&author=Berry%2CDA&author=Cheang%2CMCU
• What are the total earnings of https://doi.org/10.1016%2Fj.ejca.2012.05.023?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22766518 make?
• How much income is http://scholar.google.com/scholar_lookup?&title=Meta-analysis%20of%20the%20association%20of%20breast%20cancer%20subtype%20and%20pathologic%20complete%20response%20to%20neoadjuvant%20chemotherapy&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2012.05.023&volume=48&pages=3342-3354&publication_year=2012&author=Houssami%2CN&author=Macaskill%2CP&author=Minckwitz%2CG&author=Marinovich%2CML&author=Mamounas%2CE earning monthly?
• How much does https://doi.org/10.1038%2Fbjc.2012.524 gross monthly?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23169287?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20FOXP3%2B%20lymphocytes%20are%20asociated%20with%20cytotoxic%20immune%20responses%20and%20good%20clinical%20outcome%20in%20oestrogen%20receptor-negative%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2012.524&volume=108&pages=155-162&publication_year=2013&author=West%2CNR&author=Kost%2CSE&author=Martin%2CSD&author=Milne%2CK&author=deLeeuw%2CRJ&author=Nelson%2CBH&author=Watson%2CPH have monthly?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18802696 is on a monthly basis
• How much profit does http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20reduces%20regulatory%20Tcell%20numbers%20and%20inhibitory%20function%20and%20enhances%20the%20anti-tumor%20effects%20of%20the%20TLR9%20agonist%20PF-3512676%20in%20the%20mouse&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-008-0586-2&volume=58&pages=615-628&publication_year=2009&author=Vicari%2CAP&author=Luu%2CR&author=Zhang%2CN&author=Patel%2CS&author=Makinen%2CSR&author=Hanson%2CDC&author=Weeratna%2CRD&author=Krieg%2CAM make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22986814 bring in each month?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Intratumoral%20regulatory%20T%20cells%20as%20an%20independent%20predictive%20factor%20for%20pathological%20complete%20response%20to%20neoadjuvant%20paclitaxel%20followed%20by%205-FU%2Fepirubicin%2Fcyclophosphamide%20in%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-012-2245-8&volume=136&pages=107-116&publication_year=2012&author=Oda%2CN&author=Shimazu%2CK&author=Naoi%2CY&author=Morimoto%2CK&author=Shimomura%2CA&author=Shimoda%2CM&author=Kagara%2CN&author=Maruyama%2CN&author=Kim%2CSJ&author=Noguchi%2CS?
• How much money does https://doi.org/10.1158%2F1078-0432.CCR-09-1844 generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20145162 income
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=The%20predictive%20value%20of%20HLA%20class%20I%20tumor%20cell%20expression%20and%20presence%20of%20intratumoral%20Tregs%20for%20chemotherapy%20in%20patients%20with%20early%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1844&volume=16&pages=1272-1280&publication_year=2010&author=Kruijf%2CEM&author=Nes%2CJG&author=Sajet%2CA&author=Tummers%2CQR&author=Putter%2CH&author=Osanto%2CS&author=Speetjens%2CFM&author=Smit%2CVT&author=Liefers%2CGJ&author=Velde%2CCJ&author=Kuppen%2CPJ?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16960692
• How much income is http://scholar.google.com/scholar_lookup?&title=Metronomic%20cyclophoshamide%20regimen%20selectively%20depletes%20CD4%C2%A0%2B%C2%A0CD25%2B%20regulatory%20T%20cells%20and%20restores%20T%20and%20NK%20effector%20functions%20in%20end%20stage%20cancer%20patients&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-006-0225-8&volume=56&pages=641-648&publication_year=2007&author=Ghiringhelli%2CF&author=Menard%2CC&author=Puig%2CPE&author=Ladoire%2CS&author=Roux%2CS&author=Martin%2CF&author=Solary%2CE&author=Cesne%2CA&author=Zitvogel%2CL&author=Chauffert%2CB earning monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11325840 earn?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Cyclophosphamide%2C%20doxorubicin%2C%20and%20paclitaxel%20enhance%20the%20antitumor%20immune%20response%20of%20granulocyte%2Fmacrophage-colony%20stimulating%20factor-secreting%20whole-cell%20vaccines%20in%20HER-2%2Fneu%20tolerized%20mice&journal=Cancer%20Res&volume=61&pages=3689-3697&publication_year=2001&author=Machiels%2CJP&author=Reilly%2CRT&author=Emens%2CLA&author=Ercolini%2CAM&author=Lei%2CRY&author=Weintraub%2CD&author=Okoye%2CFI&author=Jaffee%2CEM?
• Income figures for https://doi.org/10.1002%2Fijc.23392
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18224687?
• How much income is http://scholar.google.com/scholar_lookup?&title=CCL17%20and%20CCL22%20chemokines%20within%20tumor%20microenvironment%20are%20related%20to%20accumulation%20of%20Foxp3%2B%20regulatory%20T%20cells%20in%20gastric%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.23392&volume=122&pages=2286-2293&publication_year=2008&author=Mizukami%2CY&author=Kono%2CK&author=Kawaguchi%2CY&author=Akaike%2CH&author=Kamimura%2CK&author=Sugai%2CH&author=Fujii%2CH earning monthly?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22621334
• How much does http://scholar.google.com/scholar_lookup?&title=Local%E2%80%93regional%20control%20according%20to%20surrogate%20markers%20of%20breast%20cancer%20subtypes%20and%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer%20patients%20undergoing%20breast%20conserving%20therapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr3198&volume=14&publication_year=2012&author=Caudle%2CAS&author=Yu%2CT&author=Tucker%2CSL&author=Bedrosian%2CI&author=Litton%2CJK&author=Gonzalez-Angulo%2CAM&author=Hoffman%2CK&author=Meric-Bernstam%2CF&author=Hunt%2CKK&author=Buchholz%2CTA&author=Mittendorf%2CEA gross monthly?
• What's the monthly money flow for https://doi.org/10.1634%2Ftheoncologist.2007-0107?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18245008 make?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20initial%20clinical%20disease%20stage%20after%20achieving%20pathological%20complete%20response&journal=Oncologist&doi=10.1634%2Ftheoncologist.2007-0107&volume=13&pages=6-15&publication_year=2008&author=Dawood%2CS&author=Broglio%2CK&author=Kau%2CSW&author=Islam%2CR&author=Symmans%2CWF&author=Buchholz%2CTA&author=McGuire%2CSE&author=Meric-Bernstam%2CF&author=Cristofanilli%2CM&author=Hortob%C3%A1gyi%2CGN&author=Gonzalez-Angulo%2CAM
• How much does https://doi.org/10.1200%2FJCO.2005.04.1665 pull in?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16606972?
• How much does http://scholar.google.com/scholar_lookup?&title=Sequential%20preoperative%20or%20postoperative%20docetaxel%20added%20to%20preoperative%20doxorubicin%20plus%20cyclophosphamide%20for%20operable%20breast%20cancer%3A%20National%20Surgical%20Adjuvant%20Breast%20and%20Bowel%20Project%20Protocol%20B-27&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.1665&volume=24&pages=2019-2027&publication_year=2006&author=Bear%2CHD&author=Anderson%2CS&author=Smith%2CRE&author=Geyer%2CCE&author=Mamounas%2CEP&author=Fisher%2CB&author=Brown%2CAM&author=Robidoux%2CA&author=Margolese%2CR&author=Kahlenberg%2CMS&author=Paik%2CS&author=Soran%2CA&author=Wickerham%2CDL&author=Wolmark%2CN rake in every month?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8874335?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Annual%20hazard%20rates%20of%20recurrence%20for%20breast%20cancer%20after%20primary%20therapy&journal=J%20Clin%20Oncol&volume=14&pages=2738-2746&publication_year=1996&author=Saphner%2CT&author=Tormey%2CDC&author=Gray%2CR?
• Learn how profitable https://citation-needed.springer.com/v2/references/10.1007/s10585-013-9602-9?format=refman&flavour=references is on a monthly basis
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lutfiye%20Demir?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lutfiye%20Demir%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Seyran%20Yigit produce monthly?
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Seyran%20Yigit%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hulya%20Ellidokuz is on a monthly basis
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hulya%20Ellidokuz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cigdem%20Erten?
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cigdem%20Erten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Isil%20Somali earning monthly?
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Isil%20Somali%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuksel%20Kucukzeybek
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuksel%20Kucukzeybek%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmet%20Alacacioglu makes per month
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmet%20Alacacioglu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Suna%20Cokmert pull in?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Suna%20Cokmert%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alper%20Can make?
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alper%20Can%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Murat%20Akyol?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Murat%20Akyol%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmet%20Dirican income
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmet%20Dirican%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vedat%20Bayoglu's gross income?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vedat%20Bayoglu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aysegul%20Akder%20Sari pull in?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aysegul%20Akder%20Sari%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mustafa%20Oktay%20Tarhan each month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mustafa%20Oktay%20Tarhan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• How much does https://s100.copyright.com/AppDispatchServlet?title=Predictive%20and%20prognostic%20factors%20in%20locally%20advanced%20breast%20cancer%3A%20effect%20of%20intratumoral%20FOXP3%2B%20Tregs&author=Lutfiye%20Demir%20et%20al&contentID=10.1007%2Fs10585-013-9602-9©right=Springer%20Science%2BBusiness%20Media%20Dordrecht&publication=0262-0898&publicationDate=2013-07-09&publisherName=SpringerNature&orderBeanReset=true gross monthly?
• Financial intake of https://citation-needed.springer.com/v2/references/10.1007/s10585-013-9602-9?format=refman&flavour=citation
• Learn how profitable https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral is on a monthly basis
• What's the profit of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• How profitable is https://www.springernature.com/gp/products?
• How much cash flow does https://www.springernature.com/gp/librarians have monthly?
• What's the financial outcome of https://www.springernature.com/gp/societies?
• What's the monthly money flow for https://www.springernature.com/gp/partners?
• Monthly income for https://www.springer.com/
• How much revenue does https://www.nature.com/ produce monthly?
• How much money does https://www.biomedcentral.com/ generate?
• See how much https://www.palgrave.com/ makes per month
• Learn how profitable https://www.apress.com/ is on a monthly basis
• What is the earnings of https://www.springernature.com/gp/legal/ccpa?
• What's the financial gain of https://www.springernature.com/gp/info/accessibility?
• How much does https://support.springernature.com/en/support/home rake in every month?
• What's the income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• Monthly income for https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref